Your browser doesn't support javascript.
loading
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
Park, Eunyoung; Rawson, Shaun; Li, Kunhua; Kim, Byeong-Won; Ficarro, Scott B; Pino, Gonzalo Gonzalez-Del; Sharif, Humayun; Marto, Jarrod A; Jeon, Hyesung; Eck, Michael J.
Afiliación
  • Park E; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rawson S; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Li K; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Kim BW; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ficarro SB; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Pino GG; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sharif H; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Marto JA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Jeon H; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Eck MJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Nature ; 575(7783): 545-550, 2019 11.
Article en En | MEDLINE | ID: mdl-31581174
ABSTRACT
RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival1-3. RAF activity is tightly regulated and inappropriate activation is a frequent cause of cancer4-6; however, the structural basis for RAF regulation is poorly understood at present. Here we use cryo-electron microscopy to determine autoinhibited and active-state structures of full-length BRAF in complexes with MEK1 and a 14-3-3 dimer. The reconstruction reveals an inactive BRAF-MEK1 complex restrained in a cradle formed by the 14-3-3 dimer, which binds the phosphorylated S365 and S729 sites that flank the BRAF kinase domain. The BRAF cysteine-rich domain occupies a central position that stabilizes this assembly, but the adjacent RAS-binding domain is poorly ordered and peripheral. The 14-3-3 cradle maintains autoinhibition by sequestering the membrane-binding cysteine-rich domain and blocking dimerization of the BRAF kinase domain. In the active state, these inhibitory interactions are released and a single 14-3-3 dimer rearranges to bridge the C-terminal pS729 binding sites of two BRAFs, which drives the formation of an active, back-to-back BRAF dimer. Our structural snapshots provide a foundation for understanding normal RAF regulation and its mutational disruption in cancer and developmental syndromes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microscopía por Crioelectrón / Proteínas Proto-Oncogénicas B-raf / MAP Quinasa Quinasa 1 / Proteínas 14-3-3 Límite: Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microscopía por Crioelectrón / Proteínas Proto-Oncogénicas B-raf / MAP Quinasa Quinasa 1 / Proteínas 14-3-3 Límite: Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos